Jang H, Hill NL, Turner J, Bratlee-Whitaker E, Jeong M, Mogle J. Poor-quality daily social encounters, daily stress, and subjective cognitive decline among older adults. Innov Aging. 2024 May 8. doi: 10.1093/geroni/igae038
Garcia VC, Mansfield C, Leach C, Pierce A, Smith JC, Afonso M. Patient and caregiver preferences for hemophilia treatments: a discrete-choice experiment. Haemophilia. 2024 Mar;30(2):375-87. doi: 10.1111/hae.14928
Turner JR, Hill NL, Brautigam L, Bhargava S, Mogle J. How does exposure to dementia relate to subjective cognition? A systematic review. Innov Aging. 2023 Jun 19. doi: 10.1093/geroni/igad056
Hill NL, Mogle J, Bhargava S, Bratlee-Whitaker E, Wion RK, Sweeder L, Sliwinski M, Barnes LL. Within-person associations among self-perceptions of memory, depressive symptoms, and activity participation in older adults. Gerontologist. 2021 Sep 13;61(7):1107-17. doi: 10.1093/geront/gnaa208
Bhargava S, Hill N, Mogle J. Self-reported memory problems are related to depressive symptoms in older adults with certain personality traits. Poster presented at the 2020 Gerontological Society of America (GSA) Annual Scientific Meeting; November 4, 2020. [abstract] Innov Aging. 2020 Dec 16; 4(Supplement_1,2020):389-90. doi: 10.1093/geroni/igaa057.1254
Mogle J, Hill N, Bhargava S, Bell T, Whitaker E. The factor structure of memory complaints over time. Poster presented at the Gerontological Society of America; November 2019. Austin, TX. [abstract] Innov Aging. 2019 Nov; 3(Supp 1):S221.
Hill NL, Mogle J, Bhargava S, Bell TR, Wion RK. The influence of personality on memory self-report among black and white older adults. Presented at the 2019 Gerontological Society of America (GSA) Annual Scientific Meeting; November 13, 2019. Austin, TX. [abstract] Innov Aging. 2019 Nov; 3(Suppl 1):S220.
Hill NL, Mogle J, Whitaker EB, Gilmore-Bykovskyi A, Bhargava S, Bhang IY, Sweeder L, Tiwari PA, Van Haitsma K. Sources of response bias in cognitive self-report items: "Which memory are you talking about?". Gerontologist. 2019 Sep 17;59(5):912-24. doi: doi.org/10.1093/geront/gny087
Lewis MA, Stine A, Paquin RS, Mansfield C, Wood D, Rini C, Roche MI, Powell CM, Berg JS, Bailey, Jr DB. Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment. Genet Med. 2018 Feb;20(2):181-9. doi: 10.1038/gim.2017.93
Rausch DA, Levin M, Meyers J, Candrilli S, Yan S, Krishnarajah G, Patterson B. Cost of diagnosed herpes zoster complications in patients age ≥50 years: a US claims data analysis. Poster presented at the IAGG 2017 World Congress; July 23, 2017. San Francisco, CA. [abstract] Innov Aging. 2017 Jul; 1(Suppl 1):902. doi: 10.1093/geroni/igx004.3234
Earnshaw SR, Graham CN, McDade CL, Spears JB, Kessler CM. Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment. Haemophilia. 2015 May;21(3):310-9. doi: 10.1111/hae.12621
Kruse-Jarres R, Gilsenan AW, Spears J, Kaye JA. Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry. Haemophilia. 2015 Mar;21(2):e122-4. doi: 10.1111/hae.12590
DiBenedetti DB, Coles TM, Sharma T, Pericleous L, Kulkarni R. Assessing patients' and caregivers' perspectives on stability of factor VIII products for haemophilia A: a web-based study in the United States and Canada. Haemophilia. 2014 Jul;20(4):e296-303. doi: 10.1111/hae.12459
Brown TM, Pashos CL, Joshi AV, Lee WC. The perspective of patients with haemophilia with inhibitors and their care givers: preferences for treatment characteristics. Haemophilia. 2011 May 1;17(3):476-82.
Brown TM, Lee WC, Joshi AV, Pashos CL. Health-related quality of life and productivity impact in haemophilia patients with inhibitors. Haemophilia. 2009 Jul 1;15(4):911-7.
Lee WC, Joshi AV, Woolford S, Sumner M, Brown TM, Hadker N, Pashos CL. Physicians' preferences towards coagulation factor concentrates in the treatment of haemophilia with inhibitors: a discrete choice experiment. Haemophilia. 2008 May 1;3(14):454-65.
Earnshaw SR, Wilson M, Joshi AV. The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgets. Managed Care Interface. 2007 Jan 1;19(11):39-45.
Earnshaw SR, Wilson MR, Joshi AV. Health plan budget impact analysis of recombinant activated factor VII (rFVIIa) in the treatment of intracerebral hemorrhage. Managed Care Interface. 2006;19(11):39-45.
Earnshaw SR, Candrilli SD, Fernandes AW, Higashi MK. A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia. Managed Care Interface. 2005 Oct 1;18(10):36-44.